Report on the first Latin American Consensus Conference for flow cytometric Immunophenotyping of Leukemia

Communications in Clinical Cytometry

Volumn 34, Issue 1, 1998, Pages 39-42

  Ruiz Argüelles, Alejandro ^a   Duque, Ricardo E ^b   Orfao, Alberto ^c  

^a Laboratorios Clinicos de Puebla   (Mexico)

^b LAKELAND REGIONAL MEDICAL CENTER   (United States)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Consensus; Immunophenotype; Latin America; Leukemia

Indexed keywords

ARTICLE; CONSULTATION; CYTOLOGY; DIAGNOSTIC TEST; ECONOMIC ASPECT; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LEUKEMIA; MEXICO; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0031881786     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19980215)34:1<39::AID-CYTO7>3.3.CO;2-V     Document Type: Article

References (11)

1. Almasri NM, Duque RE, Iturraspe JA, Everett ET, Braylan RC: Reduced expression of CD20 as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 40:259-263, 1992.
2. CDC 1994 Revised guidelines for the performance of CD4+ T-cells determinations in persons with human immunodeficiency virus (HIV) infection. MMWR 43:1-16, 1994.
3. Duque RE, Orfao A: Utilidad del immunofenotipo en el diagnóstico y clasificación de las leucemias crönicas. In: Actualizatión en leucemias, Ruiz-Argüelles GJ, San Miguel JF (ed). Panamericana, Mexico, 1996, pp 89-96.
4. Lanza F, for the (European) Working Group on Leukemia Immunophenotyping: Towards standardization in immunophenotyping hemato logical malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Eur J Histochem 40 Suppl 1:7-14, 1996.
5. NCCLS Document H43-P. Clinical applications of flow cytometry: Immunophenotyping of leukemic cells; proposed guideline. 23:1-107, 1993.
6. Ocquetaeu M, Orfao A, Almeida J, Blade J, Gonzalez M, Garcia-Sanz, Berges MC, Moro MJ, Hernandez J, Escribano L, Caballero MD, Rozman M, San Miguel JF: Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance (MGUS) patients. Am J Pathol (in press).
7. Rothe G, Schmitz G, Adorf D. Consensus protocols for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia 10:877-895, 1996.
8. Ruiz-Argüelles GJ, SanMiguel JF: Cell surface markers in multiple myeloma. Mayo Clin Proc 69:684-690, 1994.
9. San Miguel JF, Duque RE: Utilidad del inmunofenotipo en el diagnóstico y clasificación de las leucemias agudas. In Actualización en leucemias, Ruiz-Argüelles GJ, SanMiguel JF (eds.) Panamericana, Mexico, 1996, pp 25-34.
10. Stewart CC, Behm FG, Carey JL, Cornbleet J, Duque RE, Hudnall SD, Hurtubise PE, Loken M, Tubbs RR, Wormsley S: US-Canadian consensus recommendations on the imniunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations, Cytometry 30:231-235. 1997.
11. Tbakhi A, Edinger M, Myles J, Pohlman B, Tubbs R: Flow cytometric immunophenotyping on non-Hodgkin's lymphomas and related disorders. Cytometry 25:113- 124, 1996.